Risk communication in clinical trials: A cognitive experiment and a survey

BMC Medical Informatics and Decision Making

Volumn 10, Issue 1, 2010, Pages

  Cheung, Yin Bun ^a,b   Wee, Hwee Lin ^c   Thumboo, Julian ^d   Goh, Cynthia ^a,e   Pietrobon, Ricardo ^a,f   Toh, Han Chong ^e   Yong, Yu Fen ^a,b   Tan, Say Beng ^a,b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTHRITIS; ARTICLE; CLINICAL TRIAL (TOPIC); DECISION MAKING; EDUCATIONAL STATUS; FEMALE; HUMAN; INTERVIEW; MALE; MARRIAGE; METHODOLOGY; MIDDLE AGED; NEOPLASM; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT PREFERENCE; PSYCHOLOGICAL ASPECT; RISK; RISK REDUCTION; SINGAPORE; STATISTICS; VERBAL BEHAVIOR;

ADULT; ANALYSIS OF VARIANCE; ARTHRITIS; CLINICAL TRIALS AS TOPIC; DECISION MAKING; EDUCATIONAL STATUS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MARITAL STATUS; MIDDLE AGED; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; PATIENT PREFERENCE; RISK; RISK REDUCTION BEHAVIOR; SINGAPORE; VERBAL BEHAVIOR;

EID: 77957161743     PISSN: None     EISSN: 14726947     Source Type: Journal    
DOI: 10.1186/1472-6947-10-55     Document Type: Article

References (35)

1. Improvement of informed consent and the quality of consent documents. M Jefford R Moore, Lancet Oncol 2008 9 485 493 10.1016/S1470-2045(08)70128-1 18452859
2. Risk perception is affected by modes of risk presentation among Signaporeans. SB Tan C Goh J Thumboo W Che B Chowbay YB Cheung, Ann Acad Med Sing 2005 34 184 187
3. Statistical issues in first-in-man studies. Royal Statistical Society's Working Party on Statistical Issues in First-in-Man Studies, J R Statis Soc A 2007 170 517 519 10.1111/j.1467-985X.2007.00481.x
4. Foreword to the papers on 'The communication of risk'. A Smith, J R Statis Soc A 2003 166 205 206 10.1111/1467-985X.00267 (Pubitemid 36630325)
5. Communicating risks (Editorial). A Edwards, Bri Med J 2003 327 691 692 10.1136/bmj.327.7417.691
6. Helping doctors and patients make sense of health statistics. G Gigerenzer W Gaissmaier E Kurz-Milcke LM Schwartz S Woloshin, Psychol Sci Public Interest 2008 8 53 96
7. A test of numeric formats for communicating risk probabilities. CL Cuite ND Weinstein K Emmons G Colditz, Med Decis Making 2008 28 377 384 10.1177/0272989X08315246 18480036
8. Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations. IM Lipkus, Med Decis Making 2007 27 696 713 10.1177/0272989X07307271 17873259
9. The Ethics of Information: Absolute Risk Reduction and Patient Understanding of Screening. PH Schwartz EM Meslin, J Gen Intern Med 2008 23 867 870 10.1007/s11606-008-0616-y 18421509
10. Presenting health risk information in different formats: the effect on participants' cognitive and emotional evaluation and decisions. DR Timmermans CF Ockhuysen-Vermey L Henneman, Patient Educ Couns 2008 73 443 447 10.1016/j.pec.2008.07.013 18722073
11. How should risk be communicated to children: a cross-sectional study comparing different formats of probability information. F Ulph E Townsend C Glazebrook, BMC Med Inform Decis Mak 2009 9 26 10.1186/1472-6947-9-26 19500337
12. What are effective strategies to communicate cardiovascular risk information to patients? A systematic review. CA Waldron T van der Weijden S Ludt J Gallacher G Elwyn, Patient Educ Couns 2010 20471766
13. Aversion to side effects in preventive medical treatment decisions. EA Waters ND Weinstein GA Colditz KM Emmons, Br J Health Psychol 2007 12 383 401 10.1348/135910706X115209 17640453
14. How to improve Bayesian reasoning without instruction: frequency formats. G Gigerenzer U Hoffrage, Psychol Rev 1995 102 684 704 10.1037/0033-295X.102.4. 684
15. Numbers or words? A randomized controlled trial of presenting screen negative results to pregnant women. TM Marteau G Saidi S Goodburn J Lawton S Michie M Bobrow, Prenat Diagn 2000 20 714 718 10.1002/1097-0223(200009)20: 9<714::AID-PD906>3.0.CO;2-4 11015699
16. The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial. CL Carling DT Kristoffersen VM Montori J Herrin HJ Schünemann S Treweek EA Akl AD Oxman, PLoS Med 2009 6 1000134 10.1371/journal.pmed.1000134 19707575
17. Interpretation of and preference for probability expressions among Japanese patients and physicians. M Ohnishi T Fukui K Matsui K Hira M Shinozuka H Ezaki J Otaki W Kurokawa H Imura H Koyama T Shimbo, Fam Pract 2002 19 7 11 10.1093/fampra/19.1.7 11818343
18. Consumers' preferences for the communication of risk information in drug advertising. JJ Davis, Health Aff 2007 26 863 870 10.1377/hlthaff.26.3.863
19. 'Talking about chance': The presentation of risk information during genetic counseling for breast and ovarian cancer. N Hallowell H Statham F Murton J Green M Richards, J Gene Couns 1997 6 269 286 10.1023/A:1025624221369
20. How patients' preferences for risk information influence treatment choice in a case of high risk and high therapeutic uncertainty: asymptomatic localized prostate cancer. DJ Mazur DH Hickam MD Mazur, Med Decis Making 1999 19 394 398 10.1177/0272989X9901900407 10520677
21. Preferences and reasons for communicating probabilistic information in verbal or numerical terms. TS Wallsten DV Budescu R Zwick SM Kemp, Bull Psychonomic Soc 1993 31 135 138
22. Verbal versus numerical probabilities: Efficiency, biases, and the preference paradox. I Erev BL Cohen, Org Behav Hum Decis Proc 1990 45 1 18 10.1016/0749-5978(90)90002-Q
23. Provision of information about drug side-effects to patients. DC Berry P Knapp DK Raynor, Lancet 2002 359 853 854 10.1016/S0140-6736(02)07923-0 11897289
24. Comparison of two methods of presenting risk information to patients about the side effects of medicines. P Knapp DK Raynor DC Berry, Qual Saf Health Care 2004 13 176 80 10.1136/qshc.2003.009076 15175486
25. Cognitive considerations in designing effective labels for presenting risk information. JR Bettman JW Payne R Staelin, J Public Policy Marketing 1986 13 1 28
26. A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use. European Commission, Brussels: EC Pharmaceuticals Committee 1998
27. Order effects in the assessment of quality of life in cancer patients. YB Cheung LC Wong MH Tay CK Toh WH Koo R Epstein C Goh, Qual Life Res 2004 13 1217 1223 10.1023/B:QURE.0000037499.80080.07 15473500
28. Order effects: a randomised study of three major cancer-specific quality of life instruments. YB Cheung C Lim C Goh J Thumboo J Wee, Health Qual Life Outcomes 2005 3 37 10.1186/1477-7525-3-37 15927054
29. Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making. C Chao JL Studts T Abell T Hadley L Roetzer S Dineen D Lorenz Youssef Agha KM McMasters, J Clin Oncol 2003 21 4299 4305 10.1200/JCO.2003.06.025 14581440
30. Stata Reference Manuals Release 10. StataCorp, College Station, Texas 2007
31. Informed consent for clinical trials: A review. VM Lema M Mbondo EM Kamau, East Afr Med J 2009 86 133 142 19702101
32. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. SP Buchbinder B Metch SE Holte S Scheer A Coletti E Vittinghoff, J Acquir Immune Defic Syndr 2004 36 604 612 10.1097/00126334-200405010-00009 15097304
33. Who will enroll? Predicting participation in a phase II AIDS vaccine trial. SD Halpern DS Metzger JA Berlin PA Ubel, J Acquir Immune Defic Syndr 2001 27 281 288 11464149
34. Hypothetical and actual willingness to pay for insecticide-treated nets in five Nigerian communities. O Onwujekwe R Chima E Shu D Nwagbo P Okonkwo, Trop Med Int Health 2001 6 545 553 10.1046/j.1365-3156.2001.00745.x 11469949
35. The effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to seek treatment: a randomized trial. CL Carling DT Kristoffersen S Flottorp A Fretheim AD Oxman HJ Schünemann EA Akl J Herrin TD MacKenzie VM Montori, PLoS Med 2009 6 1000140 10.1371/journal.pmed.1000140 19707579